Literature DB >> 25887071

Evolving calciphylaxis--what randomized, controlled trials can contribute to the capture of rare diseases.

Markus Ketteler1, Patrick H Biggar2.   

Abstract

Keywords:  calcimimetics; hemodialysis; hyperparathyroidism; parathyroid hormone; vascular calcification

Mesh：

Substances：

Year:  2015        PMID： 25887071      PMCID： PMC4422232          DOI： 10.2215/CJN.03350315

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  9 in total

1.  Circulating nonphosphorylated carboxylated matrix gla protein predicts survival in ESRD.

Authors:  Georg Schlieper; Ralf Westenfeld; Thilo Krüger; Ellen C Cranenburg; Elke J Magdeleyns; Vincent M Brandenburg; Zivka Djuric; Tatjana Damjanovic; Markus Ketteler; Cees Vermeer; Nada Dimkovic; Jürgen Floege; Leon J Schurgers
Journal:  J Am Soc Nephrol       Date:  2011-02       Impact factor: 10.121

Review 2.  Vitamin K deficiency in CKD patients: a modifiable risk factor for vascular calcification?

Authors:  Thilo Krueger; Ralf Westenfeld; Markus Ketteler; Leon J Schurgers; Jürgen Floege
Journal:  Kidney Int       Date:  2009-04-22       Impact factor: 10.612

3.  Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis.

Authors:  Glenn M Chertow; Geoffrey A Block; Ricardo Correa-Rotter; Tilman B Drüeke; Jürgen Floege; William G Goodman; Charles A Herzog; Yumi Kubo; Gerard M London; Kenneth W Mahaffey; T Christian H Mix; Sharon M Moe; Marie-Louise Trotman; David C Wheeler; Patrick S Parfrey
Journal:  N Engl J Med       Date:  2012-11-03       Impact factor: 91.245

4.  Statin use and calcific uremic arteriolopathy: a matched case-control study.

Authors:  Sagar U Nigwekar; Ishir Bhan; Alexander Turchin; Stephen C Skentzos; Reza Hajhosseiny; David Steele; Rosalynn M Nazarian; Julia Wenger; Samir Parikh; Ananth Karumanchi; Ravi Thadhani
Journal:  Am J Nephrol       Date:  2013-03-21       Impact factor: 3.754

5.  A case-control study of calciphylaxis in Japanese end-stage renal disease patients.

Authors:  Matsuhiko Hayashi; Ichiro Takamatsu; Yoshihiko Kanno; Tadashi Yoshida; Takayuki Abe; Yuji Sato
Journal:  Nephrol Dial Transplant       Date:  2011-11-25       Impact factor: 5.992

6.  The Effect of Cinacalcet on Calcific Uremic Arteriolopathy Events in Patients Receiving Hemodialysis: The EVOLVE Trial.

Authors:  Jürgen Floege; Yumi Kubo; Anna Floege; Glenn M Chertow; Patrick S Parfrey
Journal:  Clin J Am Soc Nephrol       Date:  2015-04-17       Impact factor: 8.237

7.  Vitamins K and D status in stages 3-5 chronic kidney disease.

Authors:  Rachel M Holden; A Ross Morton; Jocelyn S Garland; Andrey Pavlov; Andrew G Day; Sarah L Booth
Journal:  Clin J Am Soc Nephrol       Date:  2010-02-18       Impact factor: 8.237

Review 8.  Dilemmas in the management of atrial fibrillation in chronic kidney disease.

Authors:  Holger Reinecke; Eva Brand; Rolf Mesters; Wolf-Rüdiger Schäbitz; Marc Fisher; Hermann Pavenstädt; Günter Breithardt
Journal:  J Am Soc Nephrol       Date:  2008-12-17       Impact factor: 10.121

Review 9.  Calcific uraemic arteriolopathy: a rare disease with a potentially high impact on chronic kidney disease-mineral and bone disorder.

Authors:  Vincent M Brandenburg; Smeeta Sinha; Paula Specht; Markus Ketteler
Journal:  Pediatr Nephrol       Date:  2014-01-29       Impact factor: 3.714
  9 in total
  3 in total

1.  A Nationally Representative Study of Calcific Uremic Arteriolopathy Risk Factors.

Authors:  Sagar U Nigwekar; Sophia Zhao; Julia Wenger; Jeffrey L Hymes; Franklin W Maddux; Ravi I Thadhani; Kevin E Chan
Journal:  J Am Soc Nephrol       Date:  2016-04-14       Impact factor: 10.121

Review 2.  Lessons Learned from EVOLVE for Planning of Future Randomized Trials in Patients on Dialysis.

Authors:  Patrick S Parfrey; Geoffrey A Block; Ricardo Correa-Rotter; Tilman B Drüeke; Jürgen Floege; Charles A Herzog; Gerard M London; Kenneth W Mahaffey; Sharon M Moe; David C Wheeler; Glenn M Chertow
Journal:  Clin J Am Soc Nephrol       Date:  2015-11-27       Impact factor: 8.237

3.  Calciphylaxis in Patients With Preserved Kidney Function.

Authors:  Natallia Maroz; Samer Mohandes; Halle Field; Zlata Kabakov; Richard Simman
Journal:  J Am Coll Clin Wound Spec       Date:  2015-08-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.